Evaluation of drug treatment in hepatopulmonary syndrome Evaluation of drug treatment in hepatopulmonary syndrome is not enough studied. Has been analized recent studies of drugs which are used in treatment of pulmonary vascular pathology, which includes also hepatopulmonary syndrome. Studies were done on small groups of patients and results are not concludent. Use of pentoxifiline can be most efficient in decreasining of hepatopulmonary syndrome, but is necesary to do suplimetary multidirectional study of the efficiency of treatment of hepatopulmonary syndrome.

Corijarea tratamentului medicamentos în sindromul hepatopulmonar este puţin studiat. Am analizat studiile recent efectuate şi preparatele utilizate în patologia vasculară pulmonară care include sindromul hepato-pulmonar. Studiile s-au efectuat pe loturi mici de pacienţi şi rezultatele s-au dovedit a fi neconcludente. Administrarea pentoxifilinei se pare a fi cea mai reuşită în diminuarea sindromului hepato-pulmonar, dar este necesară efectuarea cercetărilor suplimentare multidirecţionale îndreptate spre corijarea sindromului hepato-pulmonar.